Takeda Pharmaceutical Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
For the nine months, sales was JPY 3,071,322 million compared to JPY 2,695,717 million a year ago. Net income was JPY 285,883 million compared to JPY 241,417 million a year ago. Basic earnings per share from continuing operations was JPY 184.32 compared to JPY 154.09 a year ago. Diluted earnings per share from continuing operations was JPY 182.65 compared to JPY 153.03 a year ago.